Structural Cell Biology of DNA Repair Machines
Structural Cell Biology of DNA Repair Machines
批准号:
9151304
负责人:
John A. Tainer
金额:
$308.55万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-27 至 2021-08-31
关键词:
Advanced Malignant NeoplasmApoptosisAtlasesBase SequenceBiochemicalBiochemistryBiologicalBiologyBiophysicsCancer BiologyCancer EtiologyCancer InterventionCellsCellular biologyChemical AgentsChemicalsCollaborationsComplexDNADNA DamageDNA RepairDNA Repair GeneDNA Repair PathwayDataDefectElectron MicroscopyFoundationsGeneticGoalsIndividualInterventionKnowledgeLaboratoriesLeadLeftMaintenanceMalignant NeoplasmsModificationMolecularMolecular ConformationMutationOutcomePathway interactionsPatient riskPredispositionProcessProteinsRepair ComplexResearchResearch PersonnelSignal TransductionStructural BiochemistryStructureSystemTestingThe Cancer Genome AtlasTherapeuticWorkanticancer researchbasecancer cellcancer genomecancer initiationcancer therapydesigneffective therapygenome integrityinhibitor/antagonistinsightknowledge basemultidisciplinarymutantoutcome forecastpreventprogramsprotein complexresponsesingle moleculestructural biologytargeted treatment
中文摘要
整体
英文摘要
Overall
PROJECT SUMMARY/ABSTRACT
DNA repair machines are at the center of what leads to cancer-causing mutations, what prevents cancer, what
interferes with cancer treatment, and what is the Achilles heel for cancer-targeted treatment. For NCI, SBDR
coordinates leaders in DNA repair (DR) to work together synergistically to provide a comprehensive,
mechanistic understanding of DR processes. SBDR removes bottlenecks within individual laboratories and
promotes the concerted efforts of multidisciplinary researchers with expertise in different facets of DR. The
SBDR Projects and Cores together enable a comprehensive cross-pathway knowledge of dynamic multi-
functional DR machines – an understanding that can only be achieved through multi-disciplinary approaches
and concerted efforts by multiple groups. The goals of SBDR are 1) to develop structure-based, mechanistic
foundation for an actionable understanding of dynamic, multi-functional DR molecular complexes suitable for
cancer biology, prognosis, and predispositions, and 2) to enable an integrated quantitative and mechanistic
knowledge of DR machines, pathways, and intersections with replication and apoptosis sufficient to aid
prediction and intervention for cancer biology by bridging the gaps from mutant sequences to system level
correlation. By integrating analyses of major DR and damage response pathways with replication, SBDR will
provide detailed and comprehensive information on the maintenance of genetic integrity spanning from specific
proteins and complexes to pathways, networks, and signaling. We will apply knowledge-based, determination
and integration of structural, biochemical, and biological data on DR protein interactions, modifications, and
complexes acting in the five Projects. Our multifaceted structure-based strategy is needed both to dissect
multiple activities of multi-functional complexes, such as Mre11-Rad50-Nbs1, and to define how proteins act in
multiple pathways. In concert, SBDR Projects and Cores will accomplish four Program Aims: 1) Determine
definitive and biologically validated structures of DR complexes, interfaces, & conformations; 2) Dissect the
multi-functionality of DR machineries tested by structurally-based examination of separation-of-function
mutations and chemical inhibitors; 3) Define crosstalk for DR pathway interactions and delineate and test how
DR pathway choice is made; and 4) Discover synthetic lethalities brought about by either mutations or
chemical agents that target a specific DR activity that is lethal only in the context of another DR defect to
identify and test specific ways to intervene and control biological outcomes to DNA damage for cancer
interventions. SBDR will inform cancer biology by providing a comprehensive mechanistic knowledge of how
cells respond to DNA damage and how multi-functional DR proteins act in the context of other DNA processes.
SBDR will advance understanding of how DR mutations may differentially impact cancer susceptibility and
patient risk. SBDR will aid research employing Cancer Genome Atlas mutations and system level correlations
as well as consequent therapeutic strategies by providing mechanistic and predictive insights.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mesocale And Nanoscale Technologies Integrated by Structures for DNA Repair Complexes (MANTIS-DRC)
-
批准号:10687040
-
项目类别:
-
资助金额:$87.06万
-
财政年份:2018
-
负责人:John A. Tainer
-
依托单位:
Mesocale And Nanoscale Technologies Integrated by Structures for DNA Repair Complexes (MANTIS-DRC)
-
批准号:10251045
-
项目类别:
-
资助金额:$89.11万
-
财政年份:2018
-
负责人:John A. Tainer
-
依托单位:
Structural Biochemistry of DNA Dealkylation
-
批准号:8671412
-
项目类别:
-
资助金额:$3.5万
-
财政年份:2013
-
负责人:John A. Tainer
-
依托单位:
MINOS (Macromolecular Insights on Nucleic acids Optimized by Scattering)
-
批准号:8840824
-
项目类别:
-
资助金额:$53.43万
-
财政年份:2012
-
负责人:John A. Tainer
-
依托单位:
MINOS (Macromolecular Insights on Nucleic acids Optimized by Scattering)
-
批准号:8656719
-
项目类别:
-
资助金额:$53.43万
-
财政年份:2012
-
负责人:John A. Tainer
-
依托单位:
MINOS (Macromolecular Insights on Nucleic acids Optimized by Scattering)
-
批准号:8469234
-
项目类别:
-
资助金额:$53.43万
-
财政年份:2012
-
负责人:John A. Tainer
-
依托单位:
MINOS (Macromolecular Insights on Nucleic acids Optimized by Scattering)
-
批准号:8475491
-
项目类别:
-
资助金额:$51.56万
-
财政年份:2012
-
负责人:John A. Tainer
-
依托单位:
Structural Biology of XPB and XPD Helicases
-
批准号:8212285
-
项目类别:
-
资助金额:$32.82万
-
财政年份:2006
-
负责人:John A. Tainer
-
依托单位:
Structural Biology of XPB and XPD Helicases
-
批准号:7767763
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2006
-
负责人:John A. Tainer
-
依托单位:
Structural Biology of XPB and XPD Helicases
-
批准号:7096103
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2006
-
负责人:John A. Tainer
-
依托单位:
Structural Biology of XPB and XPD Helicases
-
批准号:7563283
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2006
-
负责人:John A. Tainer
-
依托单位:
Structural Biology of XPB and XPD Helicases
-
批准号:7388307
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2006
-
负责人:John A. Tainer
-
依托单位:
Structural Biology of XPB and XPD Helicases
-
批准号:8403564
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2006
-
负责人:John A. Tainer
-
依托单位:
Structural Biology of XPB and XPD Helicases
-
批准号:7284783
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2006
-
负责人:John A. Tainer
-
依托单位:
Structural Biology of XPB and XPD Helicases
-
批准号:8597520
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2006
-
负责人:John A. Tainer
-
依托单位:
Structural Cell Biology Core
-
批准号:7152390
-
项目类别:
-
资助金额:$43.51万
-
财政年份:2006
-
负责人:John A. Tainer
-
依托单位:
Structural Biology of XPB and XPD Helicases
-
批准号:8042738
-
项目类别:
-
资助金额:$32.82万
-
财政年份:2006
-
负责人:John A. Tainer
-
依托单位:
Mre11/Rad50 Structural Biology for DNA Damage Responses
-
批准号:6964707
-
项目类别:
-
资助金额:$36.72万
-
财政年份:2005
-
负责人:John A. Tainer
-
依托单位:
Mre11/Rad50 Structural Biology for DNA Damage Responses
-
批准号:7102753
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2005
-
负责人:John A. Tainer
-
依托单位:
Mre11/Rad50/Nbs1 Structural Biology for DNA Damage Responses
-
批准号:7899708
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2005
-
负责人:John A. Tainer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: